Objective: Non-adherence with medication is very common in patients with Bipolar Disorder (BD) and is the most frequent cause of recurrence. The aim of this study was to assess treatment adherence and related demographic and clinical factors in patients with bipolar disorder. Manual of Mental Disorders, fourth edition (DSM-IV) Axis II (SCID-II) was used to determine the comorbidity of personality disorders. Well, moderately, and poorly adherent patients were compared with respect to clinical and socio-demographic variables and functionality scores.
INTRODUCTION
Bipolar disorder (BD) is a life-long, disabling psychiatric disorder and can cause significant morbidity and mortality.
Treatment is a necessity to minimize the frequency of manic or depressive episodes, to reduce the severity of symptoms, to prevent patients from negative consequences of disorder, and to improve their functionality and quality of life (1) . The first-line treatment for BD is pharmacotherapies and effective medications combined with psychotherapies prove a relatively normal and productive life in 60-80% of patients. The efficacy of medications is directly related with adherence (2) .
Medication adherence can be defined as the degree to which a patient correctly follows and applies medical advice (3, 4) . Both the patient and the health-care provider affect adherence, and a positive physician-patient relationship is the most important factor in improving adherence (3) . Adherence to medical regimen has positive effects on the prognosis and is associated with lower costs of treatment. On the other hand, non-adherence is a major obstacle to the effective delivery of health care especially in chronic diseases (3) (4) (5) (6) (7) . Estimates from the World Health Organization (WHO) indicate that only about 50% of patients with chronic diseases living in developed countries follow treatment recommendations (3) .
Assessment of treatment adherence in patients with bipolar disorder
Non-adherence to the medical regimen is a very common clinical problem in the management of patients with BD. 60% of patients with BD reported that they withdraw from medication in six months (1) . More than one-third of bipolar patients discontinue the medication at least twice and nine of ten bipolar patients admitted they discontinue the medication at least once in their lives (8) .
Non-adherence is explained by "lack of insight" or as a symptom of disease for patients with mental disorders, but these conditions give limited information about medication adherence (9) . Major barriers to compliance in patients with mental disorders include age, gender, marital status, substance use, psychotic symptoms, personality disorders, lack of insight and knowledge, chronicity of disorder, poor social support, fear of stigmatization, the poor quality of information available about treatment, the complexity of medication regimens, concerns about side effects, lack of comprehension of treatment benefits, and poor communication or lack of trust between the patient and his or her clinician (10) .
There is a clear association between adherence with medication regimens and factors such as relapse, hospitalization and re-hospitalization rates; cost of treatment; incidence of suicides and so morbidity and mortality (11) (12) (13) (14) (15) . Noncompliance is the most frequent cause of recurrence in patients with BD (16) . Although most patients withdraw from medication during maintenance treatment, there are limited studies about medication adherence in euthymic bipolar patients. Knowledge of the factors associated with non-adherence and interventions that enhance adherence would result in gain in clinical management of these patients to achieve a better outcome.
The aim of this study was to assess the continuity of patients with BD to their appointments after discharge in euthymic phase, and related socio-demographic and clinical factors.
METHODS

Study Setting and Subjects
The bipolar patients who admitted to inpatient clinic of 
Procedures and Assessment Instruments
All interviews for study were made by the same psychiatrist Table 2 .
Statistical analysis
There were no statistically significant differences between the groups in comorbidity of personality disorders, functioning scores and alcohol and substance use. Table 3 shows the comorbidity of personality disorders and GAF scores of sample group and their effects on treatment adherence.
DISCUSSION
Non-adherence with medication is commonly seen and remains to be a substantial problem in the treatment of patients with BD. In this study, we aimed to describe treatment adherence and related socio-demographic and clinical factors in a group of euthymic bipolar patients and found that 70.6% of these patients to be moderately or poorly adherent to medication recommended by the clinicians.
In the literature, the rate of non-adherence with medication of patients with BD ranges between 20 to 60% (24, 25) . The rate of poorly adherent patients in our study suicide attempters may be due to these factors. We found no statistically significant differences between the groups in comorbidity of personality disorders and GAF scores.
The variability in rates and differences in studies are likely to be the consequence of the differences between methodology used, study settings and designs, the definition and assessment of adherence, the patient samples included, and the phase of disorder.
The study has a number of limitations. Our study was performed in a tertiary level hospital on a small sample group who were admitted in our inpatient clinic and have been followed in our outpatient clinic after hospital 
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